Methergine   body {font-family: 'Open Sans', sans-serif;} .ui-header .ui-title, .ui-footer .ui-title { margin-right: 0 !important; margin-left: 0 !important; } \* { margin:0px; padding:0px;} .ui-page { background: #f2f2f2 url(bg.jpg); line-height:1.5em;} #home\_link { color:#FFF; text-decoration:none; cursor:pointer; font-family:'AndikaBasicRegular',Arial, sans-serif; font-size:0.9em; margin-left:15%; } #home\_link span {font-size:0.6em;margin-left:15%; color: #D8D8D8; } h1 {font-family:'AndikaBasicRegular'; }

# Methergine

**Methergine (methylergonovine)**  
**Class:** Ergot alkaloid  
Therpeutic Class: Oxytocic  
**Anesthesia Indications:**  
C-section- uterine atony (boggy uterus) which has not responded to the Pitocin already infusing.  
**During a D&E or D& C procedure** when the doc can't stop the bleeding.  
This is a drug we never give voluntarily. The Surgeon will ask you to give it.  
A small 1mL vial 0.2mg/mL  
**MOA**  
Acts directly on the smooth muscle of the uterus and increases the tone, rate, and amplitude of rhythmic contractions.  
**Doses: Give IM**  
Standard Dose: 0.2mg IM.  
IM Q2 hr, Max is 5 doses.  
**Onset:**  
**IM:** 2-5 minutes  
**IV:** Immediate  
**PO:** 5-10 minutes  
**Duration:**  
**IM:** 3 hours  
**IV:** 45 minutes  
**PO:** 3 hours  
Not given I.V. because of risk of severe hypertension and cerebrovascular accident (CVA).  
Monitor blood pressure and uterine contractions during administration.  
If I.V. use is necessary, give dose over 1 minute.  
Diluted in 5 ml of NS.  
Most of us appear to give it IM in the anterior deltoid.  
**Tip:** If your patient has a spinal, they won't feel a thigh IM injection.  
Be aware that drug isn't routinely given I.V. because of risk of severe hypertension and cerebrovascular accident (CVA). Monitor blood pressure and uterine contractions during administration.If I.V. use is necessary, give dose over 1 minute. Dose may be diluted in 5 ml of 0.9% sodium chloride injection.  
**WARNINGS/PRECAUTIONS FOR METHERGINE**  
Sepsis. Obliterative vascular disorders. Hepatic or renal disease. 2nd stage of labor. Nursing mothers.  
  
**INTERACTIONS FOR METHERGINE**  
Potentiated by vasoconstrictors, other ergot alkaloids.  
  
**ADVERSE REACTIONS FOR METHERGINE**  
Hyper- or hypotension, nausea, vomiting, chest pain, dyspnea, headache, hematuria, thrombophlebitis, water intoxication, hallucinations, leg cramps, dizziness, tinnitus, nasal congestion, diarrhea, diaphoresis, palpitations, foul taste.  
ampuls of 1 mL, containing 0.2 mg  
**Adverse reactions**  
**CNS:** dizziness, headache, hallucination, **seizures**, CVA (with I.V. use)  
**CV:** hypertension, hypotension, transient chest pain, palpitations, **thrombophlebitis**  
**EENT:** tinnitus, nasal congestion  
**GI:** nausea, vomiting, diarrhea  
**GU:** hematuria  
**Musculoskeletal:** leg cramps  
**Respiratory:** dyspnea  
**Skin:** diaphoresis, rash, allergic reactions  
**Other:** foul taste  
1 mL, 0.2 mg, after delivery of the anterior shoulder, after delivery of the placenta, or during the puerperium. May be repeated as required, at intervals of 2-4 hours.  
**Intravenously:**  
1 mL, 0.2 mg, administered slowly over a period of no less than 60 seconds  
**Coronary artery disease:**  
Patients with coronary artery disease or risk factors for coronary artery disease (e.g., smoking, obesity, diabetes, high cholesterol) may be more susceptible to developing myocardial ischemia and infarction associated with methylergonovine-induced vasospasm.

#### Copyright Â© 2012